ENDO MED LTD

Company Registration Number:
14532769 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2025

Period of accounts

Start date: 1 January 2025

End date: 31 December 2025

ENDO MED LTD

Contents of the Financial Statements

for the Period Ended 31 December 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

ENDO MED LTD

Directors' report period ended 31 December 2025

The directors present their report with the financial statements of the company for the period ended 31 December 2025

Principal activities of the company

The principal activity of the company during the year was the provision of private medical consultancy services in gastroenterology and hepatology.



Directors

The director shown below has held office during the whole of the period from
1 January 2025 to 31 December 2025

Matthew James Long


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
24 August 2026

And signed on behalf of the board by:
Name: Matthew James Long
Status: Director

ENDO MED LTD

Profit And Loss Account

for the Period Ended 31 December 2025

2025 2024


£

£
Turnover: 5,845 0
Cost of sales: 0 0
Gross profit(or loss): 5,845 0
Distribution costs: 0 0
Administrative expenses: ( 3,072 ) 0
Other operating income: 0 0
Operating profit(or loss): 2,773 0
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0 0
Profit(or loss) before tax: 2,773 0
Tax: ( 564 ) 0
Profit(or loss) for the financial year: 2,209 0

ENDO MED LTD

Balance sheet

As at 31 December 2025

Notes 2025 2024


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks:   0 0
Debtors: 3 2,045 0
Cash at bank and in hand: 728 1
Investments:   0 0
Total current assets: 2,773 1
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 4 ( 564 ) 0
Net current assets (liabilities): 2,209 1
Total assets less current liabilities: 2,209 1
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): 2,209 1
Capital and reserves
Called up share capital: 1 1
Share premium account: 0 0
Other reserves: 0 0
Profit and loss account: 2,208 0
Total Shareholders' funds: 2,209 1

The notes form part of these financial statements

ENDO MED LTD

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 24 August 2026
and signed on behalf of the board by:

Name: Matthew James Long
Status: Director

The notes form part of these financial statements

ENDO MED LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover represents the amounts receivable for medical consultation and endoscopy services provided during the accounting period, excluding VAT where applicable. Turnover is recognised when the services have been provided and the amount receivable can be measured reliably. Income is recognised regardless of whether payment has been received by the year end.

ENDO MED LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 0 0

ENDO MED LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Debtors

2025 2024
£ £
Trade debtors 1,044 0
Prepayments and accrued income 0 0
Other debtors 1,001 0
Total 2,045 0
Debtors due after more than one year: 0 0

ENDO MED LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Creditors: amounts falling due within one year note

2025 2024
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 564 0
Accruals and deferred income 0 0
Other creditors 0 0
Total 564 0

ENDO MED LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

5. Loans to directors

Name of director receiving advance or credit: Matthew James Long
Description of the transaction:
Director’s loan for personal expenses
£
Balance at 31 December 2024
Advances or credits made: 1,500
Advances or credits repaid: 719
Balance at 31 December 2025 781